新华制药(000756.SZ)获得硫酸氨基葡萄糖胶囊药品注册证书

Core Viewpoint - Xinhua Pharmaceutical (000756.SZ) has received approval from the National Medical Products Administration for the registration certificate of Glucosamine Sulfate Capsules, which are primarily used for the treatment of primary and secondary osteoarthritis [1] Group 1 - The approval signifies a regulatory milestone for the company, enhancing its product portfolio in the pharmaceutical market [1] - Glucosamine Sulfate Capsules are aimed at addressing a significant medical need in the treatment of osteoarthritis, a common joint disorder [1]